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All animals develop in association with complex microbial communities. It is now well 
established that commensal microbiota is essential for the correct functionality of each 
organ in the host. Particularly, the commensal gastro-intestinal microbiota (CGIM) is a 
key factor for development, immunity and nutrient conversion, rendering them bio-avail-
able for various uses. Thus, nutritional inputs generate a positive loop in maintaining 
host health and are essential in shaping the composition of the CGIM communities. 
Probiotics, which are live exogenous microorganisms, selectively provided to the host, 
are a promising concept for manipulating the microbiota and thus for increasing the 
host health status. Nevertheless, most mechanisms induced by probiotics to fortify the 
immune system are still a matter of debate. Alternatively, prebiotics, which are non-di-
gestible food ingredients, can favor the growth of specific target groups of CGIM. Several 
metabolites are produced by the CGIM, one of the most important are the short-chain 
fatty acids (SCFAs), which emerge from the fermentation of complex carbohydrates. 
SCFAs have been recognized as key players in triggering beneficial effects elicited by 
simple diffusion and by specific receptors present, thus, far only in epithelial cells of 
higher vertebrates at different gastro-intestinal locations. However, both strategies have 
shown to provide resistance against pathogens during periods of high stress. In fish, 
knowledge about the action of pro- and prebiotics and SCFAs is still limited. Thus, in 
this review, we briefly summarize the mechanisms described on this topic for higher 
vertebrates and discuss why many of them may operate in the fish gut representing a 
model for different mucosal tissues
Keywords: fish, host–microbe, humans, immunity, microbiota, prebiotics, probiotics, vertebrates, SCFA
iNTRODUCTiON
In a broad sense, every single microorganism has been perceived to be a pathogenic threat, which, if 
uncontrolled, may cause devastating disease in complex live organisms. To understand this view, we 
only need to look at the latest scientific reports describing the impressive diversity and complexity of 
the whole microbiome of healthy individuals (1–3). Furthermore, several experimental models rang-
ing from invertebrates to higher mammals, whether conventionally raised (CONR) or germ-free 
October 2015 | Volume 6 | Article 5122
Montalban-Arques et al. Nutritional manipulation of the gut microbiota
Frontiers in Immunology | www.frontiersin.org
(GF), have provided opportunities to increase our knowledge 
of the sophisticated nature of the host–microbiome interplay in 
health and disease, with a level of experimental control hardly 
achievable in human studies (4, 5). Despite the complexity of 
studying host–microbe interactions in humans, large scale studies 
like the Human Microbiome Project or the MetaHit consortium 
has analyzed the composition of the microbiota of the human 
body, producing an enormous dataset of bacterial metagenomic 
and16S rRNA gene information. Therefore, these projects 
provided also a preliminary understanding of the biology and 
medical significance of the human microbiota and its collective 
genes (6). By contrast, in Teleost fish, as the first vertebrate group 
with full capacities to mount disease resistance strategies through 
adaptive and innate immune mechanisms, microbiome research 
lags well behind that for higher taxa. Nevertheless, efforts have 
been made to reveal the structure of the intestinal microbiome 
of a few fish species inhabiting a wide range of habitats in recent 
years (7–10), with the main achievements being attained in the 
novel host–microbe vertebrate model, the zebrafish (11–13). 
However, our knowledge of microbiota variations in fish is far 
from complete, and it is still unclear whether structural microbi-
ome alterations found in diseases, or are just an epiphenomenon. 
Complex microbial communities colonize virtually every surface 
that is exposed to the external environment in any organism 
and include members of the prokaryota, eukaryota, and viruses, 
which, together provide an enormous enzymatic capacity and 
play a key role in controlling many aspects of host physiology. 
However, the core microbiota could be instantly altered, generat-
ing dysbiosis. Such dysbiosis represents the state in which the 
microbiota ecological balance is critically disturbed, triggering 
perturbations in the meta-community structure, which may 
damage some of the less represented beneficial species, thereby 
producing pathological states at any developmental stage of the 
host (14, 15). For example, antibiotic treatment may lead to diar-
rhea since pathogen and commensal/mutualist microbes as well 
are depleted (15, 16). Therefore, in antibiotic-induced dysbiosis, 
among the several functional aspects affected, the microbiota 
losses its ability to break down fibers and starches into absorbable 
short-chain fatty acids (SCFAs), resulting in high levels of undi-
gested carbohydrates, triggering a pathological state in the host 
(17). Over the past few years, the field of immunology has been 
revolutionized by our growing understanding of the fundamental 
role played by the microbiota in the induction, education, and 
function of the vertebrate immune system, ranging from fish to 
humans (18, 19). Thus, now it is widely accepted that the microbi-
ome exerts beneficial effects on or within vertebrates to maintain 
overall health (20). In fish, interrelations between both entities are 
even more complex since microbes and animals share their outer 
environment (e.g., water), which is characterized by a high load of 
organic material, which directly supports microbial growth (21). 
Therefore, the marked differences between fish and mammals 
in immune functionality and the intrinsic selective pressures 
lead to differences in their commensal microbiota. However, it 
is of interest that the most numerous immune cells in the body 
of most vertebrates are cells resident at sites highly colonized by 
commensal bacteria, such as the skin or the gastro-intestinal (GI) 
tract. This may be a result of the formidable challenge represented 
by the multiple exposure to microbiota, food-derived antigens, 
metabolites, and pathogens that require a highly complex net-
work of regulatory pathways in the GI tract (Figure 1), which is 
only just beginning to be understood (22). Interestingly, among 
the latest achievements, functional genomics using GF vertebrate 
models colonized with selected single bacteria or defined consor-
tia show that responses to their compositionally distinct microbial 
load elicit conserved responses (12). More recently, Seedorf and 
colleagues (23), using an elegant approach, demonstrate the way 
in which xenomicrobiota from distant different foreign environ-
ments (from soil to human microbes) have the capacity to persist 
and invade vertebrates with GF guts or presenting established com-
munities, based solely on their capacity to specifically metabolize 
dietary and host carbohydrates and bile acids. These key experi-
ments clearly demonstrate the importance of the microbiota and 
the usefulness of GF animals to address a variety of mechanistic 
questions, suggesting the microbiota-directed therapy as an 
excellent approach to improve host health. Among the different 
strategies used to manipulate host–microbe interactions, diet is 
a major factor that shapes the proportional representation of the 
microbiota present in the gut and their relative gene content (24). 
Reciprocally, the configuration of the microbiota influences the 
nutritional value of food. Therefore, as in mammals, it is tempting 
to believe in the possibility of achieving a beneficial relationship 
between microbiota and host health through the manipulation of 
existing microbial communities by exogenous administration of 
live microorganisms or non-digestible substrates (probiotics and 
prebiotics, respectively, or the mix of both called synbiotics) to 
improve the health status of the host, and to prevent or even cure 
some preexisting pathologies (Figure 2) (25, 26). In this review, 
we briefly summarize the above mentioned knowledge obtained 
in higher vertebrates and propose the administration of SCFAs 
(27) as an attractive alternative to traditional approaches aimed 
to improving fish health.
HOST–MiCROBe iNTeRACTiONS
Multicellular organisms exist as meta-organisms comprised 
of both the macroscopic host and its mutualistic commensal 
microbiota. Their coexistence starts at birth, since until that time, 
all animals are believed to be sterile (28). With an estimated com-
position of 100 trillion cells, human symbionts outnumber host 
cells by at least a factor of 10, which express 10-fold more unique 
genes than their host’s genome (19). Despite the impressive load 
of microorganisms in the human body, most of commensals 
are anaerobes belonging only to three phyla: Bacteroidetes, 
Firmicutes, or Proteobacteria, in order of abundance (29). 
However, among all the tissues in a vertebrate body, the GI tract is 
home to a diverse and abundant bacterial community. In humans, 
the GI community varies, starting at the upper tract with a mod-
est 101 and culminates with an impressive 1014 cells/g in the colon 
represented by ~1000 different species, which have been well 
characterized (30–32). But, despite this high number of microbes, 
most symbiotic relationships between hosts and their commensal 
microbiota, as mentioned above generate several beneficial links 
(33–36) (Figure 1). For example, vertebrate genomes harbor a very 
limited repertoire of glycoside hydrolases, and so gut microbes 
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are essential for conferring metabolic traits to extract energy from 
the fibrous portion of plants with nutritional value (37, 38). In 
contrast to mammals, it is much more difficult to estimate the total 
bacterial species present in fish, because factors like habitat, salin-
ity, and trophic level directly shape the microbiota composition 
(10, 39). Early studies performed in zebrafish demonstrated that, 
even when reared in different environments, the GI microbiota 
presents few differences, demonstrating that the co-evolution of 
fish and their gut microbiota is stronger than the possible influ-
ence of the environmental bacteria in shaping these communities 
(12). Recently, the gut bacterial community censuses in some fish 
species have been investigated (40–44), and most studies are in 
agreement that fish GI tract harbor a bacterial load close to 108 bac-
terial cells g−1 represented by ~500 species, consisting mainly of 
aerobic or facultative anaerobe microorganisms although strict 
FiGURe 1 | Potential microbial strategies to improve gut mucosal immunity in fish. The therapeutic approach mechanisms include: (A) competitive 
exclusion for binding sites and translocation, (B) enhanced barrier function by reversing the increased intestinal permeability, (C) enhanced mucosal immunoglobulin 
IgT/Z response to enteral antigens, (D) reduction of secretion of inflammatory mediators, (e) stimulation of innate immune functions, (F) stimulate the release of 
antimicrobial peptides (AMPs) at the mucosal layer, and (G) enhanced availability of anti-inflammatory mediators by regulatory immune cells. (H) Production of 
metabolic health-enhancers like SCFAs by non-digestible prebiotics, (i) diffusion of SCFAs through the enterocytes to improve mucosa barrier functions. 
(J) Probiotics have been suggested to confer several health benefits on the host. However, their mechanisms of action are not well understood. (K) Synbiotics are a 
mix of pre- and probiotics, thus their mode of action are much more difficult to define.
anaerobes are also present (7, 11, 13). At the beginning of the 
meta-sequencing era, Rawls and colleagues reported for the first 
time a full list of the main bacterial operational taxonomic units 
(OTUs) present in the gut of zebrafish (12), and later studies 
revealed the presence of a core microbiota, dominated by gam-
maproteobacteria and Fusobacteria (45). Recently, an interesting 
study of the intestinal microbiome of Asian seabass determined 
the primary microbial gene catalogcatalogue, investigating the 
changes in microbial composition of normal and starved fish 
(46). The authors concluded that Proteobacteria, Firmicutes, 
and Bacteroidetes are the most abundant intestinal bacterial 
phyla in Asian sea bass, which, interestingly, are the same phyla 
as those observed in most fish analyzed to date (39). Therefore, 
these results reinforce the possibility of microbial manipulation 
to modify target bacterial groups present in sympatric species. 
FiGURe 2 | Host-microbial load under health and dysbiosis. Addition in diet of exogenous microbial sources may increase fish health through a host–microbe 
positive loop. Commensal gut microbes might be modulated by dietary administration of target microbes, non-digestible elements, or a mix of both. Expected 
output should turn in preventive or curative strategies. The use of pro-, pre-, and/or synbiotics is expected to restore the homeostatic stage. Assessment of the 
selected approach might be quantified, modeled, or dissected using omics tools, germ-free models, and microbiome analyses.
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However, host factors like genetic background and gut anatomy 
may influence the GI bacterial composition (47). For a complete 
review on the tools used to dissect different fish microbiomes and 
the species examined so far, we refer to the review of Llewellyn 
et  al., see: Ref. (48). Indeed, the coincidence of most intestinal 
bacterial communities in fish reveals a conservation status among 
species that provides fish with the same capacities to survive in 
the aquatic environment. Surprisingly, six of the eleven bacterial 
divisions found in adult zebrafish are also found in mice, and 
five are also shared by the adult human microbiota (12). These 
diverse microbial conformations among species, as analyzed 
by functional genomics, point to host responses shared with 
their compositionally distinct microbial communities that elicit 
conserved responses. New omics technology will permit the 
composition of specific microbial communities in any species 
to be evaluated and establish co-evolutive links among host and 
microbes, opening up the possibility to determine the balanced 
and reciprocal outputs produced among them under diverse 
scenarios (e.g., after microbial manipulation). Thus, we anticipate 
that fish microbiome research will make significant progress in 
the mid-term. To date, when GI microbes have been compared 
between mammals and herbivorous fish by UniFrac, they have 
been seen to cluster relatively close, perhaps due to a common 
gut fermentation process that leads to the production of SCFAs 
(39). This would suggest that although taxonomic composition at 
a particular body site can differ dramatically from one individual 
to another, functional composition measured from bacterial 
RNA data is well conserved. However, when focusing on RNA 
transcripts, it has been observed that variation depends on a 
subject-specific environment, which can be influenced by both 
long- and short-term regulatory changes in the gut (49). These 
results emphasize that fish commensal microbe composition 
is not a simple reflection of the microorganisms in their local 
habitat but may result from host-specific selective pressures 
within specific tissues, thereafter highly colonized by microbes, 
like the gut or skin in their different developmental stages (22). 
The impressive plasticity of the fish GI microbiota suggests that 
selective manipulation of microbes or their sub-products may 
produce health benefits without altering intestinal morphology 
or physiology.
GeRM-FRee ANiMAL MODeLS
To analyze gene expression (metagenomics), protein products 
(metaproteomics) and metabolic profiles (metabolomics), GF 
animals emerge as an indispensable tool, which may help to 
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decipher the microbiome composition, metabolic activity, and 
mechanisms used by microbiota in health and disease (50). 
This tool has already greatly contributed to understand the 
development of the vertebrate immune system, physiological 
processes, and the mechanisms responsible for inflammatory 
and neoplastic diseases (18, 51–54). Gnotobiotic models, a 
variant of GF models, are organisms with a defined microbiota, 
which can range from a single bacterial species to a known 
consortium, introduced alone, together, or sequentially in the 
host. Most GF experiments are performed with mice or rats, 
but rabbits, pigs, and fish among other species have been used 
as well. Therefore, there is much evidence on the crucial role 
of the microbiota in several physiological functions of verte-
brates, among them: the priming of neutrophils and increased 
disease resistance against viral infection (18), the initiation 
and progression of inflammation-associated colorectal neo-
plasia (50), regulation of the intestine antimicrobial RegIII 
by the probiotic species Bifidobacterium breve NCC2950, but 
not by the commensal Escherichia coli JM83 (55), increased 
susceptibility to arthritis due to deficiencies in reactive oxygen 
production (56), modifications in the properties of the gut 
mucus barrier through the lack of sufficient Protobacteria 
after transfer of cecal microbiota to GF recipients (57), or 
central changes in brain expression after feeding peptides 
(58). Consequently, comparative studies using GF models have 
demonstrated themselves to be fundamental for characterizing 
the profound interactions between the microbiota and the host. 
Interestingly, GF animals have shown defects in both the devel-
opment of the immune system and in immune responses due 
a reduced intestinal vasculature, undeveloped gut-associated 
lymphoid tissue (GALT), altered energy harvest (fecal caloric 
content), storage (weight and body fat), and expenditure 
compared with animals housed under specific pathogen-free 
(SPF) conditions (59). Therefore, it is not surprising that in 
the last decade, some interesting reports on the generation or 
usage of different GF fish models have been reported (9, 12, 
18, 60–63). Interestingly, in most of these reports, GF organ-
isms trend to be smaller than age-matched SPF organisms, 
and demonstrate reduced anxiety-like behavior, which may be 
linked to metabolic changes due to the absence of microbiota. 
However, all along the vertebrate lineage, it has been reported 
that most features, including the immune status, are largely 
restored once the microbiota are reestablished (11, 13, 18, 64). 
Therefore, despite the many difficulties still to be solved in the 
maintenance of GF fish, this biotechnology can be regarded 
as a powerful tool to address a multitude of questions about 
the coexistence of vertebrates with microorganisms and point 
to the importance of microbiota in the establishment of func-
tional immunocompetence.
BASiC FeATUReS OF THe iMMUNe 
SYSTeM
The innate immune system provides a first line of defense against 
microbes through primary responses, which includes phagocy-
tosis and the induction of inflammation. Immune-competent 
cells play a primary role in recognizing microbial-associated 
molecular patterns (MAMPs), which are diverse molecules 
not present in any of their structures, and include various 
molecules ranging from lipoproteins, lipopolysaccharide 
(LPS), flagellin, and peptidoglycan to unique bacterial nucleic 
acid structures, such as cyclic dinucleotides (CDNs) in several 
microbial types (65). These MAMPs are mainly recognized via 
pattern-recognition receptors (PRRs) that are expressed in all 
cells of a given type and grouped into two well-studied families 
with wide recognition capacities: the transmembrane Toll-like 
receptors (TLRs) and the intracytoplasmic Nod-like receptors 
(18). A wide set of TLRs have been reported in mammals (66), 
while in fish, a complete set of TLRs seems to be functional 
orthologs of their mammalian counterparts (67) (Figure  1). 
Surprisingly, recognition capacities, not simply as the com-
mensal microbial partners, are known to have the same confor-
mational, molecular, or locomotive structures as the pathogens. 
Therefore, huge efforts should be entitled by immune cells to 
initiate antimicrobial defense mechanisms mediated by several 
conserved signaling pathways among vertebrates, as illustrated 
in several recent reviews (68–71). The activation by PRRs of 
key master regulators, such as the nuclear factor-κB (NF-κB) 
and interferon-regulatory factors, promotes the production 
of powerful antimicrobial molecules, such as inflammatory 
cytokines (72) or interferons (73), respectively (Figure  1). 
However, if the threat remains, cytokines and interferon will 
instruct the immune response to switch toward a specific mode 
of action mediated through adaptive immune recognition. This 
specific response is mediated by two types of antigen receptor: 
T- and B-cell receptors. The genes encoding antigen receptors 
are assembled from variable and constant fragments through 
recombination-activating gene (RAG) protein-mediated 
somatic recombination, a process that yields a diverse repertoire 
of recognizing proteins (74). This diversity is further increased 
by additional mechanisms, such as non-templated nucleotide 
addition, gene conversion, and (in the case of B cells) somatic 
hypermutation, generating a high diversity of receptors with 
the potential to recognize almost any antigenic determinant in 
a specific manner (75). Of particular importance in fish, as in 
mammals, is T-cell activation and induced proliferation, which 
leads to a T-cell-mediated response via cytotoxic lymphocytes 
located at mucosal surfaces, such as intraepithelial lymphocytes 
(IELs) (76, 77). The development of memory allows the immune 
system to maintain a B-cell profile corresponding to a specific 
pathogen, which in the face of a second infection will proliferate 
quickly to fight it (77, 78). Although these adaptive mechanisms 
are present in fish, memory achievements are much less devel-
oped than in mammals. However, paradoxically, apart from the 
recognition mechanisms, vertebrates have developed the means 
to tolerate large populations of microbial partners to preserve 
homeostasis during their life cycles. This fine borderline sepa-
rating microbiota, health, and disease has led to an increased 
interest in the study of host–microbe relations. Interestingly, in 
mammals, it has been reported that, in addition to classic innate 
immune receptors, specific receptors with capacities to interact 
with microbial metabolites are present on immune surveillance 
cells (see section SCFAs as Key Immune Modulators). In fish, 
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the presence of such receptors which recognize specific micro-
bial metabolites deserve further experimentation.
MUCOSAL iMMUNiTY
In any host, immunity acts at different levels. Among them, all 
metazoans have a mucosal epithelium, which is one of the oldest 
and most universal modules of innate immunity. Together with 
the skin, the mucosal epithelium is the main interface between 
the host and the microbial world (including both pathogenic 
and symbiotic microorganisms). Therefore, it has important 
functions in protecting the host from pathogen invasion and in 
establishing symbiotic relationships with the host microbiota. 
Accordingly, as presented in Figure  1, mucosal epithelial cells 
and skin keratinocytes have specialized antimicrobial functions: 
for example, the production of antimicrobial peptides (AMPs), 
which limit the viability and multiplication of pathogens and 
symbiotic microorganisms that colonize these sites. The key play-
ers at the mucosal surface are the mucin-producer cells, which 
keep microbes at bay and influence microbiota distribution and 
content (75). In mammals, two secretory intestinal epithelial cells 
(IECs) lineages, namely goblet and Paneth cells, are critical for 
this function. Goblet cells form a physical and chemical defense 
barrier by producing transmembrane mucin glycoproteins and 
by secreting mucins – notably Muc2 – that cover the intestinal 
epithelium and form a two-tier inner and outer layer to prevent 
bacterial adhesion to the epithelium (79). Additionally, goblet cells 
also express AMPs sequestered in the mucinous gel (80). While 
the inner dense mucous layer restricts bacterial penetration and 
growth, the extended outer layer forms a well-suited environment 
for resident bacteria (81). More particularly, the importance of 
mucous protection in gut homeostasis is demonstrated by the 
development of spontaneous colitis in Muc2-deficient mice (82) 
and by the reduction of goblet cell numbers and depleted mucous 
secretion in inflammatory bowel disease patients. Glycosylated 
mucin proteins are metabolized by specialized mucous-degrading 
enzyme-producing bacteria. Therefore, released oligosaccharides 
are used as a food source for the growth of specific bacterial sub-
sets – notably Bacteroides fragilis and Akkermansia muciniphila, 
among others. Thus, mucin levels in host are not only bacterial 
containers, but could affect the abundance and distribution of 
defined intestinal bacterial subsets (83). In contrast to higher 
vertebrates, mucosal tissue dendritic and M cells in fish are not 
well established (84), and Peyer’s patches, mesenteric lymphoid 
nodes, IgA and J-chain have not been reported [for complete 
information on fish mucosal immunology, see Ref. (68, 70, 85, 
86)]. However, the two specialized mucosal immune molecules 
which have been unequivocally recognized in fish are worth to 
be emphasized here due to their high homology with their mam-
malian counterparts. The gut-specific immunoglobulin IgT/Z 
(77, 87–92) and the molecular identities of skin and gut mucins, 
like Muc2 (93–95). Thus, if at least IgT and Muc2-dependent 
mucus production are critical for effective management of both 
pathogenic and non-pathogenic bacteria, the induction at the GI 
tract of these key molecules through exogenous sources in the 
mucosal tissue (96, 97) is a promising therapeutic alternative in 
most vertebrates without excluding fish.
DieT AS A TOOL TO MODULATe THe 
iNTeSTiNAL MiCROBiOTA
Powered by novel technologies and major international ini-
tiatives, host–microbe research activity has transformed our 
understanding of the gut microbiota, including its interactions 
with diet and health. Multiple studies have shown that by virtue of 
their catalytic activity, the microorganisms in any vertebrate play 
a critical role in shaping the gut microbiota, GI function, immune 
regulation, and host health (98, 99). Reciprocally, our increas-
ing knowledge of the characteristics, ecology, and composition 
of the gut microbiota has intensified interest in modulating the 
gut ecosystem. Several studies using diverse vertebrate models 
like chickens (100), swine (101), mice (102), humans (103, 
104), and fish (105–109) have shown the possibility of applying 
dietary strategies to modulate the commensal gastro-intestinal 
microbiota (CGIM). Most studies suggest that the conversion of 
dietary components by intestinal bacteria leads to the formation 
of a large variety of metabolites, which may have beneficial or 
if uncontrolled adverse effects on vertebrate health (Figure  1). 
This observation is clearly illustrated in humans by a comparison 
of the incidence of inflammatory and metabolic diseases, such 
as type II diabetes, colon cancer, and asthma associated with 
“Western” diets and the low prevalence of the same associated 
with diets rich in dietary fiber, as found in rural areas (110, 111). 
Among the most recurrent GI disorders in the industrialized 
world is irritable bowel syndrome (IBS), which is present in about 
10–15% of the population and despite it being a multifactorial 
pathology, most patients report their symptoms to be triggered 
by meals or specific foods. This, together with a known dysbiosis 
linked to IBS, provides evidence regarding the impact of diet, the 
intestinal microbiota, and their inter-relation in the development 
of the disease (112). Despite representing almost half of the total 
number of vertebrates, less attention on this type of host–microbe 
studies has been done in fish (39), as described at the previous 
sections. However, due to fish appearing much earlier in evolu-
tion, their study could help us understand much better the host–
microbe co-evolution and therefore their functional importance 
on diet processing in higher vertebrates. In this regard, impressive 
advances have been observed in the development of functional 
feeds/diets. The term “functional feeds” is used to describe a 
particular type of food/feed that has added benefits that will 
improve both health status and growth promoting performance 
of the animals which ingest them, mainly by supplying additional 
compounds above and beyond the basic nutritional requirements 
for animal growth alone (113). Thus, this approach enables a 
significant shift away from chemotherapeutic and antibiotic 
treatments. In addition, the development of new feeds or diet 
strategies to ensure that both fish and the final product are of the 
highest quality (114) and replacement of fishmeal and fish oils 
with vegetable products is now being partially achieved (115). 
Unfortunately, there has been limited study of the health aspects 
of the newly designed feeds, an area that will have much more 
attention in the future (116–118). Therefore, we could say now 
that responses to these new diets are still far from elucidated and 
only some altered genes and proteins in different tissues of the fish 
have been reported (119–121). Nonetheless, a selection of several 
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additives is available for inclusion in functional feeds. Among 
them are the immunostimulants, which will not be discussed in 
this review since they directly impact immune receptors rather 
than the host–microbe axis, as opposed to probiotics, prebiotics, 
synbiotics, and ultimately the CGIM metabolites.
PROBiOTiCS
For many years, several bacteria and yeasts have been regarded for 
their health-inducing properties. The term probiotic was initially 
defined as live microorganisms which when administered in the 
diet in adequate amounts confer a health benefit on the host. The 
definition differentiates live microbes used as processing aids or 
sources of useful compounds from those that are administered 
primarily for their health benefits. A distinction between com-
mensal microorganisms and probiotics is also inferred from this 
definition. Although commensals in the gut are often the source 
of probiotic strains, until these strains are isolated and character-
ized and a credible case is presented for their health effects, they 
cannot be called “probiotics” (122). But, recent findings have 
thrown light on previously unknown aspects. Among them, 
several concerns regarding efficacy, like the absence of substanti-
ated health claims, the use of fecal microbiota transplants outside 
of the probiotic framework, or the inclusion of native colonizing 
microbes of the host with adequate safety and efficacy, have pro-
vided recent updates to the probiotic concept (122). So far, the 
most widely investigated microorganisms that display adequate 
probiotic characteristics are those from the genera Lactobacillus 
and Bifidobacterium (123). However, several other commensals, 
such as Propionibacterium, Streptococcus, Bacillus, Enterococcus, 
E. coli, and yeasts also have been investigated in this respect 
(124). However, no matter how effective they are, one concern 
associated with all the microorganisms proposed as probiotics to 
date is the large number of active proteins intimately associated 
with them, which make it difficult to define their mechanisms 
of action. Amid such considerations is the idea that if mecha-
nisms are not always well understood, their effectiveness may 
be in doubt, which is a solid reason for suggesting that using 
probiotics in humans or animals should be carefully considered. 
Nevertheless, research has encouraged speculation on how they 
work. For example, as proposed in Figure  1, they may revert 
dysbiosis and normalize the host microbiota, inhibit adhesion 
of pathogens to the epithelium, increase production of mucin 
and AMPs, strengthen the mucosal barrier, or modulate the 
immune system through enhanced cell-mediated responses 
[for a complete review on proposed modes of action in mam-
mals and fish, see Ref. (125, 126), respectively]. In fish, the use 
of probiotics has also been found to stimulate immunity (127), 
although the exact mode of action, that is, at the basis of these 
observations remains unknown. To define mechanisms in fish, 
it is much more complicated due to their extensive taxonomical 
and ecological variations, which depend on the fish species and 
bacterial strains used. Hence, not all strains are beneficial for 
all disorders or for all species, and some may be detrimental to 
some hosts, or even worse, they may aggravate health problems 
if these already exist (128). Thus, a probiotic must at least have 
the capacity to survive in the GI tract, display high resistance 
to gastric acids, lack any transferable antibiotic resistance gene, 
and have the capacity to exert clear benefits in the host through 
the modulation of the resident CGIM. Moreover, they should 
be non-pathogenic, non-toxic, and provide protection against 
disease-causing microorganisms by means of multiple conserved 
mechanisms (45). These properties have been clearly dissected in 
many excellent reviews on probiotics. However, we will simply 
mention a recent finding, which may give light to specific mecha-
nisms by describing how only a small fraction of the intestinal 
microbiota (as scarce as a single bacterial species) may confer 
infection resistance. Buffie et al. (129) described the synthesis of 
Clostridium difficile-inhibiting metabolites from host-derived bile 
salts by CGIM members. Therefore, the use of a human-derived 
Clostridium scindens isolate to augment murine C. difficile inhibi-
tion emphasizes the conservation of this finding across species 
and suggests therapeutic and diagnostic applications for a wide 
range of vertebrate species. Unfortunately, contrary to the stable 
and beneficial effects observed in higher vertebrates, the output 
of probiotics as modifiers of the CGIM in fish until now is quite 
variable (130). Therefore, different approaches with more refined 
compounds should be explored in fish.
PReBiOTiCS
A prebiotic has been defined as an ingredient selectively fermented 
by specific health-promoting bacteria that allows specific changes 
both in the composition and the activity of the GI microbiota by 
increasing the release of bacterial metabolites that confer benefits 
upon host well-being and health, while inhibiting the growth of 
pathogenic bacteria (126, 131, 132). Currently used prebiotics are 
mainly poorly digestible carbohydrates with a relatively short-
chain length classified on the basis of their molecular weight (126, 
133). According to their degree of polymerization, prebiotics are 
classified into mono-, oligo-, or polysaccharides (134). But, based 
on their physiological and biochemical properties, the carbo-
hydrates can be classified as digestible or non-digestible (135). 
Modulation of the gut microbiota by means of non-digestible 
carbohydrates is more common than using the digestible fraction, 
since they may exert several effects mediated through different 
metabolic pathways, including glucose and lipid metabolism, 
inflammatory reactions, and even changes in appetite regulation 
(136). In mammals, the administration of prebiotics, which 
include inulin-type fructans, fructo-oligosaccharides (FOS), 
galacto-oligosaccharides (GOS), xylo-oligosaccharides (XOS), 
lactulose, and human milk oligosaccharides have received 
attention and several beneficial effects have been reported 
(137–139). Such benefits include reduced intestinal low-grade 
inflammation, improved gut barrier integrity, the production 
of anti-inflammatory mediators, reduced blood cholesterol, and 
improved food assimilation or immune cellular components and 
mucosal barrier fortification (140–142). Therefore, following the 
successful trend observed in endothermic animals, several stud-
ies have proposed that feeding prebiotics, purified or mixed with 
different compounds, might be beneficial to both freshwater and 
marine cultured fish (106) [for full reviews, see Ref. (126, 128)]. 
However, investigations in some fish species have revealed that 
such an assertion is only partially true and caution must be taken 
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when administering functional foods. In support of the previ-
ous statement, experimental dietary administration of inulin in 
rats, chickens, and humans has proven effective in reducing the 
adverse impacts of intestinal dysbiosis, such as oxidative dysfunc-
tions and neurotoxicity (143) or the atrophy of lymphoid organs 
(144). Additionally, it has been suggested that inulin improves 
CGIM (145), produces several positive physiological effects 
(146), acts as an anti-obesogenic (136), prevents cardiovascular 
diseases (147), or even displays anti-cancer properties (143, 144, 
148). Therefore, it has been proposed as a promising immune 
enhancer in fish, but to date, the reported effects have been vari-
able and definitive conclusions are hard to reach (149, 150). Thus, 
as with inulin, after extensively analyzing the use and effect of 
several prebiotics in aquaculture fish, it is possible to establish 
that prebiotics can activate the innate immune system directly or 
by association with “good” microbes, but caution is needed as the 
contribution of the molecular mechanisms output will depend, 
for example, on the compound used, the species, season, and dose 
because CGIM may vary in different cycles. Therefore, we suggest 
the use in combination pro/prebiotics or alone of more refined 
compounds resulting from the fermentation of prebiotics by the 
CGIM, such as SCFAs, which have been linked with numerous 
health benefits in vivo (151), and may produce a strong and reli-
able health increase in the host.
MiCROBiAL MeTABOLiTeS
Ursell and colleagues (152) recently stated that most human gut 
microbial communities metabolize dietary ingredients in different 
ways and produce different metabolites that, in turn, can affect 
the host in several manners. However, the understanding of the 
molecular mechanisms behind their effects remains low (153). 
The use of high-throughput metabolomics has potential in this 
respect. Metabolic analysis of the gut environment comprises 
the metabolic profiling (identification and quantification) of the 
repertoire of thousands of small and large molecule metabolites 
present in the GI tract using high-throughput analytical meth-
ods. Popular approaches are the use of methods based on mass 
spectrometry (154) and nuclear magnetic resonance spectroscopy 
(155, 156). However, the complete set of metabolites has a highly 
variable chemical structure and properties and results depend on 
the host’s physiological state (157). Microbes provide the host with 
a rich range of metabolic capabilities. The availability of spectral 
networking platforms combined with open-source metabolome 
databases, such as HMDB, METLIN, LIPIDS MAPS, MassBank, 
and NIST, allows the identification and annotation of known and 
unknown metabolites from the metabolome spectral profiles (152). 
Most metabolomic studies, however, have focused on relating gut 
microbiota functionality with metabolic outcomes of the host by 
characterizing molecule metabolites in different host tissues like 
feces, plasma, urine, or other tissues (158). As such, Wikoff and 
colleagues found that many plasma metabolites consisting of 
hydrophilic carbohydrates, volatile alcohols, ketones, amino and 
non-amino organic acids, hydrophobic lipids, and complex natural 
compounds (157), were unique to CONR mice as compared with 
GF mice and that the relative signals of more than 10% of the com-
mon metabolites differed significantly between the two. In other 
studies on humanized mice, metabolomics have been applied to 
show that probiotic, prebiotic, and symbiotic induced changes of the 
gut microbiota modulate the host lipid, carbohydrate, and amino 
acid metabolism at a panorganismal scale (159). The change in the 
systemic metabolite profile resulting from gut microbiome modu-
lation is, thus, not limited to the gut but also includes other tissues. 
This illustrates that major metabolic processes are under symbiotic 
homeostatic control. Fewer studies have focused on the effect that 
gut microbiota manipulation has on the gut or fecal metabolome. 
One example is the study of Respondek and colleagues (160) in 
which the effect of short-chain FOS on the fecal metabolome was 
evaluated, showing an increased presence of conjugated fatty acids 
and a decreased presence of bile acid derivatives. Metabolomic 
studies applied to fish are few, and almost all focus on the influ-
ence that dietary treatments, toxicologically active compounds, 
or culture conditions have on the metabolite composition of 
different fish tissues (161–167). As far as known, only one study 
has assessed the gut metabolite profile in fish. The aim of Asakura 
and colleagues (168) was to investigate gut metabolic variations 
associated with fluctuations in microbial composition and struc-
ture in diverse fish species and to evaluate the effect of changing 
feed type on the co-metabolic modulations in a fish microbial 
symbiotic ecosystem. Fecal samples were used for this purpose. 
Using principal component analysis (PCA) – thus focusing on the 
overall metabolite profile rather than specific metabolites – they 
found that metabolite profiles of fish of the same species clustered 
together under natural conditions, but clustered according to feed 
type across species when cultured under controlled conditions. It 
was also observed that the metabolite profile differed significantly 
between gut content and fecal samples, suggesting that gut content 
samples provided information on the actual metabolite profile in 
the gut environment, whereas fecal samples – in general lower in 
metabolites – were indicative of absorption of the gut metabolites 
by the fish. As a consequence, the latter sample type does not seem 
suitable for providing information on the metabolites produced 
by the gut microbiota. Overall, it can be concluded that the effect 
of probiotics, prebiotics, or synbiotics on the metabolite profile 
in a fish gut, or even other tissues, has not yet been investigated 
in depth. Therefore, much research is essential to substantiate 
knowledge on how gut microbiota manipulation may be applied 
to promote immunity and fish health.
SCFAs AS KeY iMMUNe MODULATORS
The gut microbiome can be regarded as a metabolically active organ 
and modulation thereof by probiotics or prebiotics is becoming 
increasingly recognized as an important therapeutic option (107, 
169). As mentioned above, one of the primaries aims of probiotic, 
prebiotic, or synbiotic treatments in mammals and fish is the 
altered production of microbial metabolites. More specifically, 
the fermentation of prebiotic carbohydrates that escape digestion 
in the upper GI tract, leading to the production of SCFAs – 1–6 
carbons in length, mainly acetate, propionate, and butyrate – by 
intestinal microbes is targeted to stimulate the health of mam-
mals (159) and also fish (107, 170). SCFAs are the main energy 
sources of gut cells and as such play a central role in the physiol-
ogy and metabolism of the gut (171). Gut cell proliferation, cell 
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differentiation, apoptosis, mucin production, lipid metabolism, etc. 
all seem to be largely mediated by SCFAs. In mammals, however, it 
is being realized that, besides their function as energy sources for 
epithelial cells (172), SCFAs are also potential immunostimulatory 
molecules (98, 173–176), improve lymphocyte function (19, 177), 
and have immune-related effects resulting from their binding to 
the G-coupled protein receptors GPR41, GPR43, and GPR109A 
(178). GPR43 recognizes acetate, propionate, and butyrate and is 
highly expressed in neutrophils, macrophages, and monocytes; 
whereas, GPR41 expression is low or undetectable in the same 
cells (98). Immune-related effects of SCFA recognition include the 
modulation of anti-inflammatory responses, intracellular cyclic 
adenosine monophosphate (cAMP) levels, calcium levels, and 
ERK1/2 activation. For example, Maslowski et al. (179) found that 
GPR43 stimulation by SCFAs was necessary for the normal resolu-
tion of inflammatory responses in mice. Other immune regulatory 
activities of SCFAs include the inhibition of histone deacetylases 
(180, 181), regulation of autophagy (182), regulation of T cell dif-
ferentiation (174), and stimulation of heat shock protein produc-
tion (183). Although the full spectrum of molecular mechanisms 
by which SCFA regulate the development and functioning of 
immune cells remains far from known, it is clear that SCFAs play 
a central role in mammal immunity. Evidently, the same possibil-
ity holds true for fish. In fish, most PRRs homologous of higher 
vertebrates are present, and the beneficial effects described so far 
for SCFAs as the end products of microbial fermentation (184) are 
comparable to that observed in higher vertebrates, although, as far 
as we know, the immunomodulating potential of SCFAs for fish 
has not been considered. Specific receptors for SCFAs in fish cells, 
for example, have not yet been described in the literature. Using 
the HomoloGene tool of the National Center for Biotechnology 
Information (NCBI) (185), gene orthologs of GPR41 and GPR43 in 
mammals can, however, be found in the genome of zebrafish. These 
include the free fatty acid 3 (GPR41)-like gene LOC100333904 
(55.1% gene similarity with FFAR3 from Homo sapiens), and the 
free fatty acid 2 (GPR43)-like gene LOC100004095 (56.5% gene 
similarity with FFAR2 from H. sapiens). As such, it is likely that 
SCFA can stimulate immunity in fish in similar ways as they do in 
mammals. For example, the prebiotic bacterial storage compound 
poly-(-hydroxybutyrate (PHB) (186) has been shown to provide 
protection against pathogenic infections for a large variety of 
aquaculture animals including the protection of Nile tilapia 
against Edwardsiella ictaluri gly09 infection. It was suggested by 
Suguna et al. (187) that this compound acts as an immunostimu-
lator in tilapia although the mechanism is not known. Based 
on the review of Dedkova and Blatter (188), which describes 
(-hyroxybutyrate – the monomer and GI degradation product of 
PHB – as a ligand for GPR41 and GPR109 in mammals, it can be 
hypothesized that PHB acts in an immunostimulatory way in fish 
through its SCFAs. We suggest that the in vivo identification of 
SCFAs receptors in fish cells should be a primary target of future 
research to elucidate the immunomodulating effect of probiotics 
and prebiotics in fish.
CONCLUDiNG ReMARKS
From the information presented in this review, it is quite clear that, 
starting from birth or hatching, the presence of microorganisms 
within any vertebrate, from fish to humans, plays a significant role 
in the development of immunity and further capacities on disease 
resistance and health status along life. Among host commensals, 
the CGIM is of particular importance because any dysbiotic 
event at this important niche may have profound physiological 
and metabolic consequences at local and systemic levels (189). 
Therefore, any alteration on the host–microbe load may lead to 
impaired responses at different levels, mostly at the immune com-
ponent that ultimately would lead to disease. Thus, the modula-
tion of the microbial communities in the intestine through dietary 
administration of probiotics, prebiotics, or synbiotics emerges as 
a potential strategy to improve microbial metabolite production, 
the immune signaling pathways, and the host defense mechanisms 
against pathogens. Consequently, it is of vital importance to 
deepen or knowledge in the microbial profile present in specific 
species in particular conditions. This could be achieved by using 
powerful assessment strategies, like state-of-the-art omics tools, in 
either microbes or hosts, microbiome analyses which may lead to 
unequivocally identify the composition of the inhabitants of the 
GI tract and test hypothesis through the use of GF models. We 
suggest that following the proposed steps presented in Figure 2, in 
particular fish species may lead to improvements in host well-being 
and health, such as those already observed in higher vertebrates.
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